Association of Adenosine Deaminase Polymorphism With Mild Mental Retardation

Abstract

The etiology of mild mental retardation remains undefined in about 60% of cases. Even though the causes of mild mental retardation are likely to be heterogeneous, the evidence for genetic involvement is increasing, along with the development of specific diagnostic techniques. To improve our understanding of the genetic basis of mild mental retardation, we explored the role of polymorphisms of adenosine deaminase, an enzyme that is supposed to act as a neuroregulatory protein. To this end, we conducted an association study comparing children with mild mental retardation of unknown origin with two groups of controls: (1) apparently healthy children and (2) children with moderate or severe mental retardation of known etiology. Overall, 338 participants were enrolled in the study. Cases (ie, 80 children) were more likely than controls (ie, 153 healthy children and 105 children with moderate or severe mental retardation) to have the low-activity ADA-Asn 8 (ADA₁ *2) polymorphism (P < .05) and to present the ADA₁ *2/ ADA₂ *1 haplotype. No significant differences were found with respect to adenosine deaminase polymorphisms when comparing the group with moderate or severe mental retardation of known causes and healthy controls. In conclusion, our findings suggest a possible role for a low-activity genotype (ADA-8Asn) (ADA₁ *2) of adenosine deaminase in the pathogenesis of mild mental retardation. (J Child Neurol 2006;21:753—756; DOI 10.2310/7010.2006.00180).

Get full access to this article

View all access options for this article.

References

Gillberg C. , Soderstrom H. : Learning disability. Lancet 2003;362: 811—821.

Roeleveld N. , Zielhuis GA , Gabreels F. : The prevalence of mental retardation: A critical review of recent literature. Dev Med Child Neurol 1997;39:125—132.

World Health Organization, Division of Mental Health and Prevention of Substance Abuse , ICD-10 Guide for Mental Retardation , Geneva, Division of Mental Health and Prevention of Substance Abuse, World Health Organization, 1996.

American Association on Mental Retardation, Mental Retardation : Definition, Classification, and Systems of Supports, Washington, DC, American Association on Mental Retardation , 1992.

American Psychiatric Association Task Force on DSM-IV , Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, Washington, DC, American Psychiatric Association, 1994.

Chiurazzi P. , Oostra BA : Genetics of mental retardation. Curr Opin Pediatr 2000;12:529—535.

Gillberg C. : Practitioner review: Physical investigations in mental retardation. J Child Psychol Psychiatry 1997;38:889—897.

Inlow JK , Restifo LL : Molecular and comparative genetics of mental retardation. Genetics 2004;166:835—881.

Resta R. , Thompson LF : SCID: The role of adenosine deaminase deficiency. Immunol Today 1997;18:371—374.

10.

Franco R. , Casado V. , Ciruela F. , et al: Cell surface adenosine deaminase: Much more than an ectoenzyme. Prog Neurobiol 1997;52:283—294.

11.

Ruiz MA , Escriche M. , Lluis C. , et al: Adenosine A(1) receptor in cultured neurons from rat cerebral cortex: Colocalization with adenosine deaminase. J Neurochem 2000;75:656—664.

12.

Rebola N. , Rodrigues RJ , Oliveira CR , et al: Different roles of adenosine A(1), A(2A) and A(3) receptors in controlling kainateinduced toxicity in cortical cultured neurons. Neurochem Int 2005;47:317—325.

13.

Wechsler D. : Wechsler Preschool and Primary Scale of Intelligence-Revised. New York, Psychological Corporation, 1989.

14.

Wechsler D. : Wechsler Intelligence Scale For Children, Third Edition. New York, Psychological Corporation, 1991.

15.

Wechsler D. : Wechsler Adult Intelligence Scale, Third Edition, New York , Psychological Corporation, 1997 .

16.

Roid GH , Miller LJ , Lieter RG : Leiter International Performance Scale-Revised: Examiner's Manual, Wood Dale, IL, Stoelting, 1997.

17.

Sparrow SS , Balla DA , Cicchetti DV : Vineland Adaptive Behavior Scales-Expanded Form, Circle Pines, MN, American Guidance Service, 1984.

18.

Hirschhorn R. , Yang DR , Israni A. : An Asp8Asn substitution results in the adenosine deaminase (ADA) genetic polymorphism (ADA 2 allozyme): Occurrence on different chromosomal backgrounds and apparent intragenic crossover. Ann Hum Genet 1994;58 (Pt 1):1—9.

19.

Franco R. , Valenzuela A. , Lluis C. , et al: Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes . Immunol Rev 1998;161:27—42.

20.

Ciruela F. , Saura C. , Canela EI , et al: Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors. FEBS Lett 1996;380:219—223.

21.

Saura CA , Mallol J. , Canela EI , et al: Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 1998;273:17610— 17617.

22.

Curto R. , Voit EO , Cascante M. : Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man. Biochem J 1998;329(Pt 3):477—487.

23.

Vidotto C. , Fousert D. , Akkermann M. , et al: Purine and pyrimidine metabolites in children's urine. Clin Chim Acta 2003;335: 27—32.

24.

Bottini N. , De Luca D. , Saccucci P. , et al: Autism: Evidence of association with adenosine deaminase genetic polymorphism. Neurogenetics 2001;3:111—113.

25.

Lucarelli P. , Saccucci P. , Bottini N. , et al: Two-loci ADA haplotypes in autistic disorder. Am J Med Genet 2002;108:339—340.

26.

Persico AM , Militerni R. , Bravaccio C. , et al: Adenosine deaminase alleles and autistic disorder: Case-control and family-based association studies. Am J Med Genet 2000;96:784—790.

27.

Stubbs G. , Litt M. , Lis E. , et al: Adenosine deaminase activity decreased in autism. J Am Acad Child Psychiatry 1982;21:71—74.

28.

Johnston MV : Brain plasticity in paediatric neurology. Eur J Paediatr Neurol 2003;7:105—113.